Skip to main content
    M

    Mustang Bio Inc (MBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.39
    -0.03 (-7.95%)

    Market Cap: $3.20M

    Last updated: Nov 17, 2026 at 10:44 AM ET

    Mustang Bio Inc (MBIO) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Mustang Bio reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$1.92M, operating cash flow was -$5.26M and free cash flow was -$5.26M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$964.00K.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $2.43M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019$0N/AN/AN/AN/A
    Dec 2018$0N/AN/AN/AN/A
    Dec 2017$0N/AN/AN/AN/A
    Dec 2016$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Research and development-$1.52M$8.42M$41.04M$63.95M$55.71M$47.30M$36.31M$24.46M$20.38M$8.55M
    Operating income-$2.43M-$16.25M-$49.26M-$76.16M-$66.72M-$56.81M-$45.88M-$31.22M-$31.79M-$11.36M
    Net income-$1.92M-$15.75M-$51.60M-$77.53M-$66.37M-$60.02M-$46.39M-$30.66M-$31.29M-$12.65M
    EBITDA-$2.39M-$15.11M-$46.00M-$71.35M-$64.42M-$55.91M-$43.81M-$30.59M-$31.78M-$10.76M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$0$0$0$0$1.99M$0$0$0$2.88M
    Gross profit$0$0$0N/A$0$0$0$996.00K$0$0$0$2.52M
    Operating income-$1.06M-$1.17M-$1.06M-$670.00K-$624.00K-$885.00K-$253.00K-$1.02M-$1.46M-$8.54M-$5.23M-$8.74M
    Net income-$964.00K-$1.07M-$955.00K-$538.00K-$468.00K-$762.00K-$153.00K-$952.00K-$1.41M-$8.20M-$5.19M-$8.62M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents of $17.27M were 98.2% of total assets of $17.59M, against total liabilities of $8.06M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$17.59M$9.31M$17.74M$92.42M$125.17M$109.90M$73.44M$42.75M$63.49M$27.50M
    Current assets$0$8.61M$11.35M$78.85M$111.71M$99.53M$63.06M$35.13M$61.36M$27.50M
    Cash and equivalents$17.27M$6.84M$6.23M$75.66M$109.62M$97.80M$61.41M$16.47M$34.98M$27.50M
    Total liabilities$8.06M$13.18M$17.62M$46.15M$12.77M$11.46M$21.79M$6.36M$3.66M$3.22M
    Short-term debtN/A$456.00K$520.00K$612.00K$348.00K$278.00K$1.25M$0N/A$320.00K
    Long-term debtN/AN/AN/A$27.44M$0N/A$12.18M$0$0$0
    Shareholder equity$9.53M-$3.87M$123.00K$46.27M$112.40M$98.44M$51.65M$36.40M$59.83M$24.28M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$14.68M$15.61M$16.58M$17.59M$19.36M$13.05M$14.91M$9.31M$7.19M$8.52M$14.59M$17.74M
    Total liabilities$8.10M$8.07M$7.99M$8.06M$9.59M$10.15M$11.30M$13.18M$15.85M$16.85M$19.54M$17.62M
    Cash and equivalents$14.28M$15.15M$16.26M$17.27M$18.98M$12.66M$14.23M$6.84M$3.52M$4.27M$1.34M$6.23M
    Shareholder equity$6.59M$7.54M$8.60M$9.53M$9.77M$2.89M$3.61M-$3.87M-$8.66M-$8.33M-$4.94M$123.00K
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$5.26M-$11.41M-$49.48M-$65.07M-$53.67M-$37.32M-$33.58M-$19.24M-$12.95M-$4.13M
    Capital expenditures$0$0$64.00K$2.71M$3.99M$1.93M$2.35M$6.87M$424.00K$424.00K
    Free cash flow-$5.26M-$11.41M-$49.54M-$67.78M-$57.65M-$39.24M-$35.93M-$26.11M-$13.37M-$4.55M
    Dividends paid$273.00K$611.00K$477.00KN/AN/AN/AN/AN/A$320.00K$0
    Share repurchasesN/AN/A$446.00K$123.00KN/A$3.51M$2.63M$0N/AN/A
    Investing cash flow$1.17M$0$5.89M-$2.95M-$5.37M-$4.41M$13.91M$557.00K-$29.05M$0
    Financing cash flow$14.53M$11.27M-$26.08M$34.06M$70.85M$78.12M$65.12M$181.00K$49.98M$31.63M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$876.00K-$967.00K-$1.01M-$1.72M-$818.00K-$1.34M-$1.39M-$2.00M-$1.76M-$2.33M-$5.32M-$7.25M
    Capital expendituresN/AN/A$0$0$0$0$0$0$0$0$0$30.00K
    Free cash flowN/AN/A-$1.01M-$1.72M-$818.00K-$1.34M-$1.39M-$2.00M-$1.76M-$2.33M-$5.32M-$7.28M
    Last 12 quarters

    Frequently Asked Questions About MBIO

    What is Mustang Bio's annual revenue?

    Mustang Bio reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Mustang Bio profitable?

    No. Mustang Bio reported net income of -$1.92M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does MBIO generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$5.26M minus capital expenditures of $0 produced free cash flow of -$5.26M.

    How much debt does Mustang Bio have?

    The balance sheet dated Dec 31, 2025 reported cash and equivalents of $17.27M.